Additionally, serum levels of cytokines TNF-α, IL-6, and IL-1β, which are associated with Kupffer cell activation in NAFLD, were markedly inhibited in the JWQZG-treated groups in a dose-dependent manner (Figs. 4F–H). The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.